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Background: Many cardiovascular diseases (CVDs) require patients to take one or more long term medications, often administered multiple times 
a day. We sought to determine the effect of chronic CVD medication dosing frequency on medication adherence.
Methods: A search of Medline and Embase from 1986-August 2011 was performed. Included studies used a prospective design, assessed adults 
with chronic CVDs, evaluated scheduled oral medications administered one to four times daily, and measured adherence for ≥1 month using an 
electronic monitoring device. Mixed linear model metaregression was used to determine how dosing frequency - after adjustment for other study 
level factors - affected adherence using 3 definitions of increasing strictness (“lenient”, “stricter” and “strictest”).
Results: A total of 29 studies, comprising 41, 29 and 27 dosing frequency arms for the lenient, stricter and strictest adherence definitions were 
included. Crude pooled adherence estimates were highest when the lenient definition was assessed (range for dosing frequencies: 80.1%-93.1%), 
and lowest when the strictest definition was assessed (range: 57.1%-76.3%). Upon metaregression, the adjusted weighted mean percent adherence 
for twice and three times daily dosing regimens (no studies evaluated four times daily regimens), were 6.9% and 13.7% lower than once daily 
regimens for the lenient, 14.0% and 27.5% lower for the stricter, and 22.9% and 30.4% lower for the strictest adherence definition (p<0.05 for 
all). Other study level factors found to significantly impact adherence included enrollment of heart failure patients (stricter adherence increased 
by 25.7%), publication after year 2000 (lenient adherence decreased by 5.7% and stricter adherence decreased by 12.8%), use of a randomized 
trial design (lenient adherence decreased by 6.6%) and follow up lasting ≥6 month (lenient adherence decreased by 10.5%). These latter findings; 
however, were not consistent across all adherence definitions.
Conclusion: Patients appear to be more adherent with once daily compared with more frequently scheduled chronic CVD medication regimens. 
This finding is magnified when more stringent definitions of adherence are used.
